Related Experiment Video
Updated: May 1, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA-mediated regulation of melanoma
1Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, 475 Brannan St Suite 220, San Francisco, CA, 94107, U.S.A.
Melanoma, a deadly skin cancer, lacks effective treatments for advanced stages due to poorly understood molecular drivers. MicroRNAs (miRNAs) are key regulators in melanoma development and metastasis, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma is an aggressive skin cancer with high mortality, particularly in advanced stages.
- Current treatments are limited, especially for metastatic disease, highlighting a need for better understanding of its molecular progression.
- Genetic and epigenetic alterations are implicated in melanoma development and metastasis.
Purpose of the Study:
- To review current data on microRNAs (miRNAs) involved in melanoma.
- To highlight deregulated miRNAs targeting key genes and pathways in melanoma progression.
- To discuss the potential clinical utility of miRNAs as biomarkers and therapeutic targets.
Main Methods:
- Literature review of studies on miRNAs in melanoma.
- Analysis of identified deregulated miRNAs and their targeted genes/pathways.
- Evaluation of the role of miRNAs in melanocyte transformation and metastasis.
Main Results:
- MicroRNAs (miRNAs) are emerging as critical regulators in melanoma initiation and progression.
- Specific deregulated miRNAs target crucial genes and pathways driving melanoma development and metastasis.
- miRNAs play a significant role in the transition from primary to metastatic melanoma.
Conclusions:
- MicroRNAs are pivotal in melanoma pathogenesis and progression.
- Targeting specific miRNAs holds promise for novel melanoma therapies.
- miRNAs may serve as valuable biomarkers for early detection and prognosis of melanoma.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

